Patient-Reported Outcomes Promos Need “Substantial Evidence,” FDA Says
Executive Summary
Promotion using patient reported outcomes requires "substantial evidence" supporting patients' claims, FDA Division of Drug Marketing, Advertising & Communication's Director Thomas Abrams said
You may also be interested in...
Patient-Reported Outcome Claims In Labeling Should Be Specific To Evidence
Patient-reported outcome instruments that measure simple concepts are not adequate to support complex claims in labeling, FDA said
Patient-Reported Outcome Claims In Labeling Should Be Specific To Evidence
Patient-reported outcome instruments that measure simple concepts are not adequate to support complex claims in labeling, FDA said
Is A Picture Worth A Thousand Words? – FDA Evaluation Of DTC Images Urged
FDA should consider the impact of images on consumer behavior as part of its evaluation of direct-to-consumer advertisements, the National Research Center for Women & Families suggested